SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-026303
Filing Date
2024-02-22
Accepted
2024-02-22 07:01:26
Documents
16
Period of Report
2024-02-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm246832d1_8k.htm   iXBRL 8-K 26521
2 EXHIBIT 99.1 tm246832d1_ex99-1.htm EX-99.1 120528
6 GRAPHIC tm246832d1_ex99-1img01.jpg GRAPHIC 2801
  Complete submission text file 0001104659-24-026303.txt   342986

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rytm-20240222.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rytm-20240222_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rytm-20240222_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT tm246832d1_8k_htm.xml XML 3619
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38223 | Film No.: 24662248
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)